CTOs on the Move


 
Oncura is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.oncura.com
  • 3350 N Ridge Ave
    Arlington Heights, IL USA 60004
  • Phone: 800.228.0126

Executives

Name Title Contact Details

Similar Companies

Allen Medical Systems

Our goal at Allen Medical Systems is to provide the highest product innovation and technology to our customers. Our most recent step in achieving that objective has been to include the products of OR Direct, Hill-Rom Surgical Surfaces, and Ronci

Bionik Laboratories

Bionik Laboratories (OTCQB: BNKL), is a global, pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders. Through the acquisition of Interactive Motion Technologies, Bionik has added a portfolio of products focused on upper and lower extremity rehabilitation of stroke patients.

tei biosciences inc

tei biosciences inc is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stimwave Technologies

Stimwave Technologies Inc is a privately-held medical device company engaged in the development, manufacture, commercialization and marketing of wireless microsize injectable medical devices for neurology markets. Stimwave strives to improve people`s lives through utilizing wireless neurostimulation technology that enables low cost alternatives to complicated and expensive surgery, coupled with convenient and safe methods of use easily incorporated into everyday life.

HeartBeam

HeartBeam, Inc. (NASDAQ: BEAT) is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting at any time and any place. Its breakthrough solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution. No single lead ECG technology can offer this value to patients and their physicians. This underserved market is several times larger than the cardiac arrhythmia detection market based on the prevalence of patients with coronary artery disease at high risk of heart attack